Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FLETCHER BUILDING LIMITED Director's Dealing 2024

Nov 11, 2024

64902_rns_2024-11-11_53a10ab7-9d35-4816-b382-3241b88e3cc6.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [452 x 69] intentionally omitted <==

D&O Initial Disclosure

Auckland, 12 November 2024: Please see attached the Initial Disclosure Notice for Kylie Eagle of Fletcher Building Limited (“FBU”).

ENDS

Authorised by: Haydn Wong Company Secretary

For further information please contact:

MEDIA

Christian May Chief Corporate Affairs Officer +64 21 305 398 [email protected]

INVESTORS AND ANALYSTS Aleida White Head of Investor Relations +64 21 155 8837 [email protected]

Fletcher Building Limited, Private Bag 92114, Auckland 1142, 810 Great South Road, Penrose, Auckland 1061, New Zealand

==> picture [101 x 27] intentionally omitted <==

Initial Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of which issuer listed or appointment made:

Fletcher Building Limited 12 November 2024 11 November 2024

Director or senior manager giving disclosure

Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:

Kylie Maree Eagle Fletcher Building Limited N/A Chief People Officer

Summary of relevant interest (excluding specified derivatives)

Class of quoted financial product(s): Nature of relevant interest(s): Number held in class: Current registered holder(s):

Ordinary Shares in Fletcher Building Limited 4,955 Beneficial interest Kylie Maree Eagle

Summary of specified derivatives relevant interest (if applicable)

Type of derivative: Class of underlying financial products: Details of derivative The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): A statement as to whether the derivative is cash settled or physically settled: Maturity date of the derivative (if any): Expiry date of the derivative (if any): The price specified in the terms of the derivative (if any): Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: For that derivative,- Parties to the derivative: If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:

==> picture [216 x 71] intentionally omitted <==

Not Applicable

==> picture [216 x 46] intentionally omitted <==

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

Signature of director or officer: Date of signature:

by all persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
Signature of person authorised to sign on behalf of director or officer:
Date of signature: 12 November 2024
Name and title of authorised person: Haydn Wong, Company Secretary

Notes

Use this form to disclose the relevant interests that a director or senior manager of a listed issuer has in quoted financial products of the listed issuer or a related body corporate or a specified derivative. The disclosure must be made within 5 trading days of —

(a) the listing of the public issuer; or

(b) the person's appointment as a director or senior manager.